Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 EUR | -3.66% | -5.84% | -14.13% |
04-05 | GenSight: financial visibility assured until the end of April | CF |
03-25 | GenSight: share price falls, limited financial visibility | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.13% | 33.2M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- GenSight Biologics S A : Expects EU Decision on Eye Disorder Drug Lumevoq in Q4